KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Astrana Health (ASTH) over the last 15 years, with Q3 2025 value amounting to $2.6 million.

  • Astrana Health's Capital Expenditures rose 1119.83% to $2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.6 million, marking a year-over-year decrease of 2376.36%. This contributed to the annual value of $8.0 million for FY2024, which is 7184.97% down from last year.
  • As of Q3 2025, Astrana Health's Capital Expenditures stood at $2.6 million, which was up 1119.83% from $1.4 million recorded in Q2 2025.
  • Over the past 5 years, Astrana Health's Capital Expenditures peaked at $17.5 million during Q1 2022, and registered a low of $98000.0 during Q1 2021.
  • Its 5-year average for Capital Expenditures is $4.5 million, with a median of $2.8 million in 2024.
  • Its Capital Expenditures has fluctuated over the past 5 years, first surged by 1774591.84% in 2022, then tumbled by 9387.76% in 2024.
  • Astrana Health's Capital Expenditures (Quarter) stood at $2.8 million in 2021, then crashed by 68.39% to $886000.0 in 2022, then skyrocketed by 696.5% to $7.1 million in 2023, then crashed by 64.13% to $2.5 million in 2024, then grew by 0.83% to $2.6 million in 2025.
  • Its Capital Expenditures was $2.6 million in Q3 2025, compared to $1.4 million in Q2 2025 and $3.1 million in Q1 2025.